Aigen Investment Management’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-6,507
Closed -$362K 970
2025
Q3
$362K Sell
6,507
-8,597
-57% -$460K 0.06% 488
2025
Q2
$777K Buy
+15,104
New +$759K 0.11% 301
2023
Q2
Sell
-38,553
Closed -$2.86M 960
2023
Q1
$2.86M Buy
38,553
+16,549
+75% +$1.28M 0.39% 62
2022
Q4
$1.82M Sell
22,004
-5,636
-20% -$448K 0.26% 114
2022
Q3
$1.96M Buy
+27,640
New +$2.39M 0.28% 106
2021
Q4
Sell
-1,724
Closed -$209K 1182
2021
Q3
$209K Buy
+1,724
New +$210K 0.04% 411
2020
Q4
Sell
-8,436
Closed -$522K 1045
2020
Q3
$522K Buy
+8,436
New +$549K 0.07% 387
2020
Q2
Sell
-872
Closed -$41K 1266
2020
Q1
$41K Buy
872
+820
+1,577% +$41K 0.01% 1021
2019
Q4
$3K Buy
+52
New +$2.73K ﹤0.01% 1038

Other funds holding TECH

Aigen Investment Management's TECH Position: Q4 2025 in Review

Aigen Investment Management sold out of Bio-Techne (TECH) in Q4 2025, closing a stake of 6,507 shares — an estimated $362K sold.

Aigen Investment Management first reported a position in TECH in Q4 2019 and held it in 9 quarters. The position peaked at $2.86M in Q1 2023. 584 funds tracked by Wall St. Rank hold TECH as of Q4 2025.

  • Aigen Investment Management reported no remaining Bio-Techne position as of Q4 2025 after selling out during the quarter.
  • Aigen Investment Management sold 6,507 Bio-Techne shares in Q4 2025, an estimated $362K.
  • Aigen Investment Management first reported a position in Bio-Techne in Q4 2019 and held it in 9 quarters.
  • Aigen Investment Management's Bio-Techne position peaked at $2.86M in Q1 2023.
  • 584 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2025.

Based on Aigen Investment Management's 13F filing for Q4 2025, filed 13 Feb 2026.